Discuss this article at www.facebook.com/CurrentPsychiatry
In a survey of 115 college students taking medication for attention-deficit/hyperactivity disorder (ADHD), 31% reported having taken their drugs more frequently or at a higher dose than prescribed, or used someone else’s medication since beginning college.1 Fifty-six percent reported being asked to give or sell their medication in the past 6 months; 26% of those solicited gave or sold their medication to a peer.1 The 3 most frequently reported reasons for misusing ADHD medications centered on studying: to improve concentration, to lengthen study time, and to feel less restless while studying.1
Although treating ADHD with first-line stimulants may reduce the incidence of substance use disorders,2,3 monitor patients closely to ensure therapeutic drugs are not being misused or abused.
- Use screening tools such as the CRAFFT test4 for adolescents and the 5-question RAFFT test for adults.5 Also, consider toxicology screenings.
- Consider extended-release formulations, which can reduce recreational stimulant use because subjective likeability is more strongly influenced by the drug delivery rate than by plasma concentration.
- Consider other medications/formulas such as a transdermal patch delivery of methylphenidate or prodrug formulations such as lisdexamfetamine, which is gut enzyme-dependent to hydrolyze into lysine and d-amphetamine. Also, consider nonstimulants such as atomoxetine, bupropion, or tricyclic antidepressants.
- Rule out mood disorders, especially depression, which may be driving the urge to get “high.”
- Involve family members or other forms of supervision, who may be able to better monitor medications.
- Improve physician/patient communication because active physician involvement and better patient communication about treatment-related issues is better for all involved.
- Provide triplicate prescriptions in person to avoid “prescriptions lost in the mail,” and keep a log of all prescriptions you dispense.
Disclosure
Dr. Jain reports no financial relationship with any company whose products are mentioned in this article or with manufacturers of competing products.